Edwards Lifesciences Corp (NYSE:EW)

152.87
Delayed Data
As of Jun 22
 +0.69 / +0.45%
Today’s Change
100.20
Today|||52-Week Range
155.22
+35.63%
Year-to-Date
Medical Device Industry Outlook - June 2018
Jun 14 / Zacks.com - Paid Partner Content
Boston Scientific Up on Possible Takeover Bid by Stryker
Jun 12 / Zacks.com - Paid Partner Content
How to Play the New Hawkish Fed
Jun 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close152.18
Today’s open152.77
Day’s range151.76 - 154.10
Volume1,106,297
Average volume (3 months)1,347,294
Market cap$29.1B
Data as of 4:01pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+3.45%
Earnings growth (this year)+21.76%
Earnings growth (next 5 years)+17.95%
Revenue growth (last year)+15.91%
P/E ratio58.8
Price/Sales7.08
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.19+0.51%
ISRGIntuitive Surgical-3.87-0.79%
STESTERIS plc-0.34-0.32%
HRCHill-Rom Holdings In...-0.11-0.12%
Data as of 4:04pm ET, 06/22/2018

Financials

Next reporting dateJuly 25, 2018
EPS forecast (this quarter)$1.13
Annual revenue (last year)$3.4B
Annual profit (last year)$583.6M
Net profit margin16.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts